You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
McKesson
Dow
Moodys
Harvard Business School

Last Updated: July 11, 2020

DrugPatentWatch Database Preview

Patent: 9,339,617

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,339,617
Title:Nasal delivery device
Abstract: The present invention provides an air-intake device for delivering a substance to the nasal cavity of a subject which comprises: a container for containing the substance; a nosepiece and a mouthpiece extending from the device, for placement in proximity to the nose and mouth of the subject, respectively; a valve mechanically connectable to the container, with an active configuration and an inactive configuration; and, a trigger mechanism to reconfigure the valve from the active configuration to the inactive configuration, and vice versa. The trigger mechanism is activated by intaking air through the mouthpiece by the subject. Drawing air from the mouthpiece reconfigures the valve from its inactive configuration to its active configuration for a predetermined period of time and delivers the substance from the device to a nasal cavity of the subject.
Inventor(s): Shahaf; Daniel (M.P. Emek Ha-Yarden, IL), Hadash; Joseph (Lapid, IL)
Assignee: SIPNOSE LTD. (Yokneam, IL)
Application Number:13/783,620
Patent Claims:see list of patent claims

Details for Patent 9,339,617

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Start Trial SIPNOSE LTD. (Yokneam, IL) 2039-03-29 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Start Trial SIPNOSE LTD. (Yokneam, IL) 2039-03-29 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Start Trial SIPNOSE LTD. (Yokneam, IL) 2039-03-29 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
AstraZeneca
Medtronic
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.